Beyond the Abstract - Role of sorafenib in renal cell carcinoma: Focus on ... - UroToday PDF Print

Beyond the Abstract - Role of sorafenib in renal cell carcinoma: Focus on ...
UroToday
When we consider renal cell carcinoma, the median age of diagnosis is 65 years old. Concerning the six drugs currently approved for the treatment of kidney cancer, only a few elderly patients are enrolled in phase III registration studies.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.